Literature DB >> 12943682

Protein disregulation in red blood cell membranes of type 2 diabetic patients.

Ming Jiang1, Linzhi Jia, Weihua Jiang, Xiaojian Hu, Hanqing Zhou, Xin Gao, Zhiqiang Lu, Zhihong Zhang.   

Abstract

The proteomics analysis was used to search for the membrane proteins related to the type 2 diabetes in human red blood cell (RBC). To improve the solubilization and separation for membrane proteins during two-dimensional electrophoresis (2-DE), several types of chaotropes and surfactants were tested. The optimized condition was then screened. About 1000 protein spots from RBC membranes can be resolved on the 2-D gel. To compare the 2-DE patterns between RBC membranes of type 2 diabetic patients and healthy controls, a total of 42 proteins that were differentially expressed were found. The analysis shows that flotillin-1, a recently discovered membrane protein of RBC lipid rafts, appears to be affected in the disease. The result would be quite interesting because flotillin-1 in adipocytes functions is related to stimulate activation of glucose transporter 4 in response to insulin. Additionally, syntaxin 1C and arginase were also disregulated in patient RBC membranes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943682     DOI: 10.1016/s0006-291x(03)01559-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms.

Authors:  Ahna R Skop; Hongbin Liu; John Yates; Barbara J Meyer; Rebecca Heald
Journal:  Science       Date:  2004-05-27       Impact factor: 47.728

Review 2.  Proteomics: applications in transfusion medicine.

Authors:  Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

3.  Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.

Authors:  Qibin Zhang; Matthew E Monroe; Athena A Schepmoes; Therese R W Clauss; Marina A Gritsenko; Da Meng; Vladislav A Petyuk; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2011-06-10       Impact factor: 4.466

4.  Diabetes-induced vascular dysfunction involves arginase I.

Authors:  Maritza J Romero; Jennifer A Iddings; Daniel H Platt; M Irfan Ali; Stephen D Cederbaum; David W Stepp; Ruth B Caldwell; Robert W Caldwell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 5.  Vascular dysfunction in retinopathy-an emerging role for arginase.

Authors:  Ruth B Caldwell; Wenbo Zhang; Maritza J Romero; R William Caldwell
Journal:  Brain Res Bull       Date:  2009-09-06       Impact factor: 4.077

6.  Diabetes-induced coronary vascular dysfunction involves increased arginase activity.

Authors:  Maritza J Romero; Daniel H Platt; Huda E Tawfik; Mohamed Labazi; Azza B El-Remessy; Manuela Bartoli; Ruth B Caldwell; Robert W Caldwell
Journal:  Circ Res       Date:  2007-10-25       Impact factor: 17.367

7.  Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes.

Authors:  Qibin Zhang; Ning Tang; Athena A Schepmoes; Lawrence S Phillips; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2008-04-09       Impact factor: 4.466

8.  Systems Epidemiology: A New Direction in Nutrition and Metabolic Disease Research.

Authors:  Marilyn C Cornelis; Frank B Hu
Journal:  Curr Nutr Rep       Date:  2013-12

Review 9.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

10.  Arginase as a mediator of diabetic retinopathy.

Authors:  Chintan Patel; Modesto Rojas; S Priya Narayanan; Wenbo Zhang; Zhimin Xu; Tahira Lemtalsi; Kanjana Jittiporn; R William Caldwell; Ruth B Caldwell
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.